156 related articles for article (PubMed ID: 15292288)
1. Improving neonatal screening for congenital adrenal hyperplasia.
Speiser PW
J Clin Endocrinol Metab; 2004 Aug; 89(8):3685-6. PubMed ID: 15292288
[No Abstract] [Full Text] [Related]
2. Steroid profiling by tandem mass spectrometry improves the positive predictive value of newborn screening for congenital adrenal hyperplasia.
Minutti CZ; Lacey JM; Magera MJ; Hahn SH; McCann M; Schulze A; Cheillan D; Dorche C; Chace DH; Lymp JF; Zimmerman D; Rinaldo P; Matern D
J Clin Endocrinol Metab; 2004 Aug; 89(8):3687-93. PubMed ID: 15292289
[TBL] [Abstract][Full Text] [Related]
3. Newborn screening for congenital adrenal hyperplasia: additional steroid profile using liquid chromatography-tandem mass spectrometry.
Janzen N; Peter M; Sander S; Steuerwald U; Terhardt M; Holtkamp U; Sander J
J Clin Endocrinol Metab; 2007 Jul; 92(7):2581-9. PubMed ID: 17456574
[TBL] [Abstract][Full Text] [Related]
4. Steroid profiling for congenital adrenal hyperplasia by tandem mass spectrometry as a second-tier test reduces follow-up burdens in a tertiary care hospital: a retrospective and prospective evaluation.
Seo JY; Park HD; Kim JW; Oh HJ; Yang JS; Chang YS; Park WS; Lee SY
J Perinat Med; 2014 Jan; 42(1):121-7. PubMed ID: 23989111
[TBL] [Abstract][Full Text] [Related]
5. Neonatal 17-hydroxyprogesterone levels adjusted according to age at sample collection and birthweight improve the efficacy of congenital adrenal hyperplasia newborn screening.
Hayashi GY; Carvalho DF; de Miranda MC; Faure C; Vallejos C; Brito VN; Rodrigues AS; Madureira G; Mendonca BB; Bachega TA
Clin Endocrinol (Oxf); 2017 Apr; 86(4):480-487. PubMed ID: 27978607
[TBL] [Abstract][Full Text] [Related]
6. Pilot proficiency testing study for second tier congenital adrenal hyperplasia newborn screening.
De Jesús VR; Simms DA; Schiffer J; Kennedy M; Mei JV; Hannon WH
Clin Chim Acta; 2010 Nov; 411(21-22):1684-7. PubMed ID: 20619255
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of neonatal screening for congenital adrenal hyperplasia.
Honour JW; Torresani T
Horm Res; 2001; 55(4):206-11. PubMed ID: 11598376
[TBL] [Abstract][Full Text] [Related]
8. Timely neonatal screening.
Dhondt JL; Farriaux JP
J Med Screen; 1999; 6(2):112-3. PubMed ID: 10444733
[No Abstract] [Full Text] [Related]
9. The adjustment of 17-hydroxyprogesterone cut-off values for congenital adrenal hyperplasia neonatal screening by GSP according to gestational age and age at sampling.
Jiang X; Tang F; Feng Y; Li B; Jia X; Tang C; Liu S; Huang Y
J Pediatr Endocrinol Metab; 2019 Nov; 32(11):1253-1258. PubMed ID: 31603856
[TBL] [Abstract][Full Text] [Related]
10. Determination of a steroid profile in heel prick blood using LC-MS/MS.
Boelen A; Ruiter AF; Claahsen-van der Grinten HL; Endert E; Ackermans MT
Bioanalysis; 2016; 8(5):375-84. PubMed ID: 26891684
[TBL] [Abstract][Full Text] [Related]
11. [Usefulness of molecular analysis in the differential diagnosis of congenital 21-hidroxylase deficiency detected in neonatal screening].
Soriano Guillén L; Velázquez De Cuellar Paracchi M; Ezquieta B
Med Clin (Barc); 2011 Mar; 136(7):313-4. PubMed ID: 19766262
[No Abstract] [Full Text] [Related]
12. [Neonatal screening for congenital adrenal hyperplasia in Shanghai areas].
Gu X; Zhou J; Ye J
Zhonghua Yu Fang Yi Xue Za Zhi; 2002 Jan; 36(1):16-8. PubMed ID: 11955341
[TBL] [Abstract][Full Text] [Related]
13. Use of steroid profiling by UPLC-MS/MS as a second tier test in newborn screening for congenital adrenal hyperplasia: the Utah experience.
Schwarz E; Liu A; Randall H; Haslip C; Keune F; Murray M; Longo N; Pasquali M
Pediatr Res; 2009 Aug; 66(2):230-5. PubMed ID: 19390483
[TBL] [Abstract][Full Text] [Related]
14. Cortisol assay in dried blood spots to reduce false positive rate in congenital adrenal hyperplasia screening.
Brossaud J; Barat P; Fagour L; Corcuff JB
Clin Chim Acta; 2012 Aug; 413(15-16):1306-7. PubMed ID: 22561187
[No Abstract] [Full Text] [Related]
15. Screening for congenital adrenal hyperplasia: the Delfia Screening Test overestimates serum 17-hydroxyprogesterone in preterm infants.
al Saedi S; Dean H; Dent W; Stockl E; Cronin C
Pediatrics; 1996 Jan; 97(1):100-2. PubMed ID: 8545200
[TBL] [Abstract][Full Text] [Related]
16. Neonatal screening for congenital adrenal hyperplasia: transitory elevation of 17-hydroxyprogesterone.
Huidobro Fernández B; Echeverria Fernández M; Dulin Iñiguez E; Ezquieta Zubicaray B; Roldán Martín MB; Rodríguez Arnao MD; Rodríguez Sánchez A
J Pediatr Endocrinol Metab; 2011; 24(3-4):155-62. PubMed ID: 21648283
[TBL] [Abstract][Full Text] [Related]
17. Concurrent Confirmation and Differential Diagnosis of Congenital Adrenal Hyperplasia from Dried Blood Spots: Application of a Second-Tier LC-MS/MS Assay in a Cross-Border Cooperation for Newborn Screening.
Monostori P; Szabó P; Marginean O; Bereczki C; Karg E
Horm Res Paediatr; 2015; 84(5):311-8. PubMed ID: 26397944
[TBL] [Abstract][Full Text] [Related]
18. Effect of single and multiple courses of prenatal corticosteroids on 17-hydroxyprogesterone levels: implication for neonatal screening of congenital adrenal hyperplasia.
Gatelais F; Berthelot J; Beringue F; Descamps P; Bonneau D; Limal JM; Coutant R
Pediatr Res; 2004 Nov; 56(5):701-5. PubMed ID: 15371568
[TBL] [Abstract][Full Text] [Related]
19. Possible andrologic markers in elevated neonatal 17-hydroxyprogesterone.
Cavarzere P; Vincenzi M; Gaudino R; Franceschi R; Perlini S; Camilot M; Teofoli F; Antoniazzi F; Tatò L
Fertil Steril; 2010 Nov; 94(6):2350-2. PubMed ID: 20537623
[TBL] [Abstract][Full Text] [Related]
20. Neonatal screening for congenital adrenal hyperplasia.
White PC
Nat Rev Endocrinol; 2009 Sep; 5(9):490-8. PubMed ID: 19690561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]